Progression of Obesity Influences Risk of Diabetes Over Life Course

Share this content:
Progression of Obesity Influences Risk of Diabetes Over Life Course
Progression of Obesity Influences Risk of Diabetes Over Life Course

THURSDAY, March 8, 2018 (HealthDay News) -- Changes in weight influence the risk of diabetes, with lower risk of diabetes for obese individuals who lose weight versus stable obesity, according to a study published online March 5 in Diabetes Care.

Andrew Stokes, Ph.D., from the Boston University School of Public Health, and colleagues categorized individuals into four weight-change groups from young adulthood to midlife: stable non-obese, losing (moved from obese to non-obese), gaining (moved from non-obese to obese), and stable obese. Weight change was related to incident diabetes over 10 years of follow-up.

The researchers found that, compared to those with stable obesity, those who were obese and lost weight had a significantly lower risk of diabetes (hazard ratio [HR], 0.33). Lower risk was also seen for those who were stable non-obese (HR, 0.22) and those in the gaining category (HR, 0.70). Compared with individuals who were stable non-obese, there was evidence of an increased incidence of diabetes among obese individuals who lost weight; weight loss was rare and the correlation was not statistically significant. During the 10-year period, an estimated 9.1 percent of observed diabetes cases could have been averted if those who were obese had become non-obese; 64.2 percent of cases could have been averted if the population had maintained a normal body mass index.

"The findings from this study underscore the importance of population-level approaches to the prevention and treatment of obesity across the life course of individualS," the authors write.

Several authors disclosed financial ties to Johnson & Johnson and Ethicon (a Johnson & Johnson Company), which partially funded the study.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves First Customizable Insulin Pump

FDA Approves First Customizable Insulin Pump

Product works by delivering insulin under the skin at set or variable rates

Sepsis Common in Terminal Hospitalizations, Discharges

Sepsis Common in Terminal Hospitalizations, Discharges

Most common underlying causes of death in sepsis are solid and hematologic cancers, chronic heart disease

Fewer Older Men Assessed, Treated for Osteoporosis

Fewer Older Men Assessed, Treated for Osteoporosis

Fewer older men than women, even with higher risk, undergo DXA screening, 25(OH)D measurement

is free, fast, and customized just for you!




Already a member?

Sign In Now »